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each community, were utilized to determine the additional
bias introduced by ampliﬁcation and/or sequencing reagents.
Signiﬁcant differences were noted in alpha and beta di-
versity of samples extracted using each protocol, particularly
as compared to the expected values, consistent with pre-
vious ﬁndings. Additionally, there were unexpected genera
found within these communities indicating contamination
uniquely introduced by each protocol. Trends were noted
among different kits, in either over- or under-representa-
tion of speciﬁc genera of communities. Similar trends were
observed in the results of sequencing controls, indicating
the contamination and/or bias introduced after extraction.
Overall, these ﬁndings illustrate the importance of utilizing
controls at multiple stages of the process, to better assess the
impact of the ﬁndings of any human samples.
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Implementation of Multiplex Staining, Imaging and
Analysis as a Standardized Service for Researchers
Shanmugapriya Selvaraj1, Valeria Mezzano1,
Branka Brukner Dabovic1, Cynthia Loomis1
1NYU Langone Medical Center
Several modalities of multiplex immunoﬂuorescence
histology currently available require signiﬁcant time and
resources to implement. Many research laboratories develop
questions beneﬁting from multiplex staining and analysis
but do not have the human resources and/or equipment to
perform the assay. Furthermore, pilot studies use similar
metrics to evaluate multiplex histology data making them
ideal for a core laboratory setup. The objective of this study
was to establish a semi-automated workﬂow for multiplex
immunoﬂuorescence staining and initial quantiﬁcation of
cell populations in whole slide microscopy scans. The
requirements for the workﬂow included: A. minimal transfer
of decision making from the researcher to core personnel
(Semi-Automation), B. modiﬁable in terms of antigen
targets and tissue types with minimal disruption to the
process and C. reproducible across samples submitted
at different time periods (eg patient samples). Methods:
Leica Bond RX auto stainer was used for staining. Akoya
Biosciences Phenoptics platform was used for multiplex
staining, imaging was performed with the Vectra3 multi-
spectral imaging system followed by InForm quantiﬁcation.
Further analysis was conducted with the statistical analysis
package R. Cross platform imaging was tested with a Zeiss
880 confocal microscope. Results: Five investigators are
using the workﬂow for their projects that range from
clinical pilot studies to basic science with animal models.
Our workﬂow for one slide involves 24 hours for staining,
one hour for scanning setup, 10 minutes for whole slide
scanning, up to 2 hours for automated sampling, and initial
analysis setup 2 hours. Conclusions: the key steps for
establishing a robust workﬂow include antibody optimiza-
tion using a combination of chromogenic (for determination
of speciﬁcity/sensitivity) and ﬂuorescent testing in multiplex
panels (to determine appropriate dilution according to
corresponding ﬂuorophore). Explicit statement from the
researchers regarding what to quantify (populations of in-
terest, areas of interest) optimizes analysis output.
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Incorporating In-Source Fragments Improves
Metabolite Identiﬁcation Accuracy in Untargeted
LCMS and LCMS/MS Datasets
Brian C. Searle1, Jacob C. Lippincott2,
Phillip M. Seitzer2
1Institute for Systems Biology, 2Proteome Software
In untargeted metabolomics experiments library search
engines detect metabolites using several features, including
precursor mass, isotopic distribution, retention time, and
MS2 fragmentation. Matching acquired MS2 to library
spectra is vital as numerous compounds share molecular
formulas, resulting in identical precursor measurements and
similar retention times. However, many metabolomics
experiments are still collected using LC-MS only, and even
in LC-MS/MS experiments many precursors lack MS2
spectra due to the stochastic nature of data dependent ac-
quisition. We observe that when metabolites ionize they
can produce unanticipated MS1 features resulting from
neutral losses, in-source fragmentation, multimerization,
and adducts. Here we present a new approach to leverage
these measurements to identify metabolites when MS2
spectra are of low quality or not available. We processing
datasets of 75 known standards mixed with whole yeast
lysates to strip them of their MS2 scans to produce a gold-
standard MS1-only data set of a complex metabolome with
known targets. For each dataset we determined the pro-
portion unambiguous annotations (where the correct
annotation had a higher score than other potential anno-
tations) and unmistakable annotations (where the correct
annotation was the only valid annotation detected). We
found that incorporating in-source fragments improved
these metrics for both MS1-only (increasing from 60%
to 73% unambiguous and 40% to 65% unmistakable
matches) and MS2 datasets (from 79% to 84% unambig-
uous and 41% to 60% unmistakable). Unexpectedly, in
these data we observed that the MS2 spectra were less
useful than in-source fragment data for improving identi-
ﬁcation accuracy. We believe this is largely because the low-
resolution iontrap MS2 spectra collected in this experiment
show signiﬁcant noise, which diminishes spectral match
scores and allows other candidates to outscore the correct
identiﬁcations. We suspect that noise is less likely to affect
MS1 peak groups because they are generated from data
aggregated across multiple high-resolution MS1 scans.
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Infectious Disease Metagenomics: Error Mitigation
and Best Practices for the Clinical Routine Use of
Metagenomic Sequencing
Nur A. Hasan1, Huai Li2, Brian Fanelli2,
Arne Materna2, Manoj Dadlani2, Rita R. Colwell3
1CosmosID, University of Maryland, 2CosmosID, 3University
of Maryland, Johns Hopkins Bloomberg School of Public
Health, CosmosID
Shotgun metagenomic sequencing is increasingly adop-
ted by the biomedical community for clinical infection
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